Following a successful beta phase, MOCTeledoc is already cash-flow positive, validating its business model and operational strategy. The management anticipates that this new division will contribute significantly to the company's revenue streams, complementing its existing compounding and direct-to-consumer divisions, which reported $25.9 million in revenue for the nine months ending December 31, 2025.
The launch of MyOnlineConsultation.com finalizes ETST's healthcare ecosystem by integrating its prescriber network with its compounding pharmacies, RxCompound and Mister Meds, as well as external pharmacies. This vertical integration is expected to streamline operations and enhance service delivery, ultimately driving cross-divisional revenue.
CEO Giorgio R. Saumat expressed optimism about the new platform, stating, "Achieving cash-flow-positive results during our beta phase confirms the power of our product, and we anticipate this division will be immediately accretive to our bottom line as we roll it out nationwide. By offering our custom platform and dedicated prescriber network as a turnkey service, we have not only created a new revenue stream but also established a powerful funnel for our in-house pharmacies."
The strategic move to launch MyOnlineConsultation.com is expected to position Earth Science Tech as a key player in the telehealth market, which has seen significant growth in recent years. With the ongoing demand for accessible healthcare solutions, ETST's initiative aligns with current market trends and consumer needs, potentially leading to increased market share and profitability in the future.
